INVESTINGFDA Asks Sanofi to Pull Zantac From the Market, Citing Cancer RiskBy Annie GausApr 1, 2020 4:51 PM EDT
HEALTHCoronavirus Latest Updates: A Timeline of Recent EventsBy Steve FiorilloMar 30, 2020 12:05 PM EDT
INVESTINGRegeneron, Sanofi Enroll First Person Outside of U.S. in Coronavirus Treatment TestBy Tony OwusuMar 30, 2020 9:04 AM EDT
JIM CRAMERMarket Turning Point?: Cramer's 'Mad Money' Recap (Friday 3/27/20)By Scott RuttMar 27, 2020 8:43 PM EDT
INVESTINGRegeneron Launches US Trials for Coronavirus Treatment With France's SanofiBy Martin BaccardaxMar 16, 2020 11:16 AM EDT
INVESTINGInovio Among Pharma Firms Prepping to Hit Go on Coronavirus VaccineBy M. Corey GoldmanFeb 28, 2020 10:32 AM EST
INVESTINGSanofi Joins Race for Coronavirus Vaccine as Death Toll MountsBy Scott Van VoorhisFeb 18, 2020 11:59 AM EST
INVESTINGFrance's Sanofi to Buy Cancer-Drug Specialist Synthorx for $68-Share, or $2.5 BillionBy Tony OwusuDec 9, 2019 10:53 AM EST
INVESTINGMerck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 BillionBy Martin BaccardaxDec 9, 2019 9:47 AM EST
STOCKSPfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema DrugBy Martin BaccardaxSep 27, 2019 9:50 AM EDT
MARKETSFDA Says Sanofi's Zantac Medication Has Impurity That Could Cause CancerBy Brenda BouwSep 13, 2019 1:01 PM EDT
MARKETSUniQure Jumps on Report It's Exploring a Possible SaleBy Joseph WoelfelJun 17, 2019 9:33 AM EDT
STOCKSElon Musk Has Lost It and Must Consider Bringing In Facebook's Sheryl SandbergBy Brian SozziAug 17, 2018 9:04 AM EDT
POLITICSDrug Pricing Turns to Insulin As Politicians, AMA And Docs Look to PharmaBy Bill MeagherJun 22, 2018 8:02 PM EDT
MARKETSEli Lilly's Trulicity benefits from growth of diabetes drugsBy Armie Margaret LeeMay 23, 2018 1:39 PM EDT
POLITICSTrump administration rolls out shaming as drug pricing toolBy Bill MeagherMay 16, 2018 3:02 PM EDT
MERGERS AND ACQUISITIONSAceto's search for deal may be slowed by DOJ subpoenaBy Bill MeagherApr 25, 2018 6:25 PM EDT
STOCKSPhilippine FDA Says Sanofi of Knew of Vaccine's Dangers in 2015By Tony OwusuFeb 26, 2018 3:07 PM EST
HEALTHKey measure for generic drug access left out of federal budgetBy Bill MeagherFeb 9, 2018 5:34 PM EST
MERGERS AND ACQUISITIONSStock Market Drop Not Seen Dampening Healthcare Deal ActivityBy Armie Margaret LeeFeb 8, 2018 6:48 PM EST
STOCKSSanofi announces second billion-dollar deal in a week, and it may not be doneBy Armie Margaret LeeJan 29, 2018 1:59 PM EST
FUTURES5G, Sanofi, Ablynx, Coincheck and Bruno Mars - 5 Things You Must Know Before the Market OpensBy Joseph WoelfelJan 29, 2018 7:42 AM EST
